Equibles does not estimate personal net worth.
Get an email with a short summary when Lemaitre Vascular Inc publishes a filing, an earnings call transcript or a press release.
Get LMAT alertsGeorge LeMaitre is recorded as CEO at Lemaitre Vascular Inc (LMAT). The newest filing on record that lists George LeMaitre as CEO at Lemaitre Vascular Inc (LMAT) is dated April 14, 2026. The proxy statement of Lemaitre Vascular Inc reports total compensation of $2,220,797 for George LeMaitre in fiscal 2023, including a base salary of $592,659. Disclosed compensation is on record for 7 fiscal years. George LeMaitre has spoken on 23 earnings calls and 8 other investor events across 1 company, most recently for Lemaitre Vascular Inc on September 22, 2026. Lemaitre Vascular Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Lemaitre Vascular Inc includes Dorian LeBlanc (CFO), David Hissong (General Counsel), John A. Roush (Board Member) and 6 others.
“Artigraph grew 34% in Q2, accounting for 21% of sales. Graphs up 23%, Shunts up 18%, and Patches up 4%. Each posted records, as did EMEA, up 18 percent, APAC, up 18 percent, and the Americas up 5 percent.”
“Artigraph grew 34% in Q2, accounting for 21% of sales. Graphs up 23%, Shunts up 18%, and Patches up 4%. Each posted records, as did EMEA, up 18 percent, APAC, up 18 percent, and the Americas up 5 percent.”
“Artograph grew 34% in Q2, accounting for 21% of sales. Graphs, up 23%, Shunts, up 18%, and Patches, up 4%, each posted records, as did EMEA, up 18%, APAC, up 18%, and the Americas up 5%.”
“Q1 featured 11% sales growth, a 72.7% gross margin, and 42% EPS growth. Graphs were up 20%, Valvatome's 15%, and Carotid Chunk's 11%, as each category posted record sales.”
“Q1 featured 11% sales growth, a 72.7% gross margin, and 42% EPS growth. Graphs were up 20%, Valvatome's 15%, and Carotid Chunk's 11%, as each category posted record sales.”
Start not stated–present
Last confirmed April 14, 2026
Medical Instruments & Supplies · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $592,659 | $2,220,797 |
| 2022 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $568,498 | $1,940,112 |
| 2021 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $473,470 | $1,982,030 |
| 2020 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $310,564 | $1,386,506 |
| 2019 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $437,750 | $1,397,744 |
| 2018 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $437,750 | $1,404,207 |
| 2017 | Lemaitre Vascular Inc (LMAT) | Chairman and Chief Executive Officer | $162,392 | $888,982 |
